Your search for esrd returned 1 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Diana Ernst, RPh remove
Older than 2 years remove
Drugs in the Pipeline remove

Your search for esrd returned 1 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

Invokana Gets FDA’s Priority Review for CKD in T2D Indication

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for Invokana (canagliflozin; Janssen) to reduce the risk of end-stage renal disease (ESRD) and renal or cardiovascular (CV) death in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD).